Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of socioeconomic factors on time to diagnosis of childhood cancer.
Goncalves C, Rouger J, Pellier I, Parienti JJ, Lejeune J, Grain A, Rod J, Gandemer V, Delehaye F. Goncalves C, et al. Among authors: gandemer v. Pediatr Hematol Oncol. 2024 Nov 29:1-17. doi: 10.1080/08880018.2024.2434876. Online ahead of print. Pediatr Hematol Oncol. 2024. PMID: 39611287
Childhood Langerhans cell histiocytosis hematological involvement: severity associated with BRAFV600E loads.
Thalhammer J, Jeziorski E, Marec-Berard P, Barkaoui MA, Pagnier A, Rohrlich PS, Chevallier A, Carausu L, Aladjidi N, Rigaud C, Leruste A, Azarnoush S, Lauvray T, Le Louet S, Gandemer V, Treguier P, Mansuy L, Pasquet M, Olivier L, Rome A, Saultier P, Isfan F, Renard C, Li Thiao Te V, Salmon A, Blanc L, Abou Chahla W, Lambilliotte A, Stephan JL, Geissmann F, Lejeune J, Mallebranche C, Reguerre Y, Grain A, Thomas C, Hélias-Rodzewicz Z, Moshous D, Fenneteau O, Coulomb-L'hermine A, Lapillonne H, de Saint Basile G, Emile JF, Héritier S, Donadieu J. Thalhammer J, et al. Among authors: gandemer v. Blood. 2024 Nov 1:blood.2024025625. doi: 10.1182/blood.2024025625. Online ahead of print. Blood. 2024. PMID: 39486044
Long-term outcome after allogeneic stem cell transplantation for GATA2 deficiency: An analysis of 67 adults and children from France and Belgium.
Sicre de Fontbrune F, Chevillon F, Fahd M, Desseaux K, Poiré X, Forcade E, Sterin A, Neven B, Gandemer V, Thepot S, Garnier A, Lioure B, Marcais A, Nguyen-Quoc S, Tavitian S, Vincent L, Donadieu J, Resche Riggon M, Chevret S, Pasquet M, Peffault de Latour R. Sicre de Fontbrune F, et al. Among authors: gandemer v. Br J Haematol. 2024 Aug 19. doi: 10.1111/bjh.19691. Online ahead of print. Br J Haematol. 2024. PMID: 39159950
Ruxolitinib for pediatric patients with treatment-naïve and steroid-refractory acute graft-versus-host disease: the REACH4 study.
Locatelli F, Kang HJ, Bruno B, Gandemer V, Rialland F, Faraci M, Takahashi Y, Koh K, Bittencourt H, Cleary G, Rosko C, Li X, St Pierre A, Prahallad A, Diaz-de-Heredia C. Locatelli F, et al. Among authors: gandemer v. Blood. 2024 Nov 14;144(20):2095-2106. doi: 10.1182/blood.2023022565. Blood. 2024. PMID: 39046767 Clinical Trial.
Impact of age on safety of Busulfan-Melphalan followed by autologous hematopoietic stem-cell transplantation versus standard chemotherapy in the patients of the EURO-E.W.I.N.G. 99 and Ewing 2008 clinical trials.
Choderlos de Laclos X, Risbourg S, Brennan B, Bertucci F, Gaspar N, Gelderblom H, Hawkins DS, Janeway K, Juergens H, Kasper B, Krailo MD, Cécile Le Deley M, Marec-Bérard P, McCabe MG, Metzler M, Ranft A, Strauss S, Tabone MD, Windsor R, Dirksen U, Gandemer V. Choderlos de Laclos X, et al. Among authors: gandemer v. Eur J Cancer. 2024 Sep;208:114229. doi: 10.1016/j.ejca.2024.114229. Epub 2024 Jul 15. Eur J Cancer. 2024. PMID: 39032218 Free PMC article. Clinical Trial.
No clear benefit of preventive cranial radiotherapy in childhood Philadelphia-positive acute lymphoblastic leukemia: a retrospective analysis of the EsPhALL2010 study.
Conter V, Valsecchi MG, De Lorenzo P, Gandemer V, Heyman M, Saha V, Diaz P, Li CK, Attarbaschi A, Escherich G, Stary J, Schrappe M, Pieters R, Cario G, Biondi A. Conter V, et al. Among authors: gandemer v. Haematologica. 2024 Nov 1;109(11):3766-3770. doi: 10.3324/haematol.2024.285253. Haematologica. 2024. PMID: 39021218 Free PMC article. No abstract available.
Childhood myelodysplastic syndromes: Is cytoreductive therapy useful before allogeneic hematopoietic stem cell transplantation?
Le Calvez B, Jullien M, Dalle JH, Renard C, Jubert C, Sterin A, Paillard C, Huynh A, Guenounou S, Bruno B, Gandemer V, Buchbinder N, Simon P, Pochon C, Sirvent A, Plantaz D, Kanold J, Béné MC, Rialland F, Grain A; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM‐TC). Le Calvez B, et al. Among authors: gandemer v. Hemasphere. 2024 Jul 8;8(7):e120. doi: 10.1002/hem3.120. eCollection 2024 Jul. Hemasphere. 2024. PMID: 38978638 Free PMC article.
NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients.
Simonin M, Vasseur L, Lengliné E, Lhermitte L, Cabannes-Hamy A, Balsat M, Schmidt A, Dourthe ME, Touzart A, Graux C, Grardel N, Cayuela JM, Arnoux I, Gandemer V, Huguet F, Ducassou S, Lhéritier V, Chalandon Y, Ifrah N, Dombret H, Macintyre E, Petit A, Rousselot P, Lambert J, Baruchel A, Boissel N, Asnafi V. Simonin M, et al. Among authors: gandemer v. Blood. 2024 Oct 10;144(15):1570-1580. doi: 10.1182/blood.2023023754. Blood. 2024. PMID: 38848537
A predictive classifier of poor prognosis in transplanted patients with juvenile myelomonocytic leukemia: a study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.
Meyran D, Arfeuille C, Chevret S, Neven Q, Caye-Eude A, Lainey E, Petit A, Rialland F, Michel G, Plantaz D, Jubert C, Theron A, Gandemer V, Ouachée-Chardin M, Paillard C, Bruno B, Buchbinder N, Pochon C, Calvo C, Fahd M, Baruchel A, Cavé H, Dalle JH, Strullu M. Meyran D, et al. Among authors: gandemer v. Haematologica. 2024 Sep 1;109(9):2908-2919. doi: 10.3324/haematol.2023.284103. Haematologica. 2024. PMID: 38385260 Free PMC article.
Therapeutic drug monitoring of imatinib - how far are we in the leukemia setting?
Buhl Rasmussen AS, Andersen CL, Weimann A, Yang T, Tron C, Gandemer V, Dalhoff K, Rank CU, Schmiegelow K. Buhl Rasmussen AS, et al. Among authors: gandemer v. Expert Rev Clin Pharmacol. 2024 Mar;17(3):225-234. doi: 10.1080/17512433.2024.2312256. Epub 2024 Feb 12. Expert Rev Clin Pharmacol. 2024. PMID: 38345044 Review.
220 results